BERLIN — Pairing a screening or surveillance colonoscopy with a same-day esophagogastroduodenoscopy (EGD) proved feasible and yielded clinically relevant upper gastrointestinal (GI) findings, ...
Kelly, MD, MBA, and participants discussed key considerations for biomarker testing in upper GI cancers. Biomarker status has ...
Aurora, Colo. (Aug. 24, 2022) – Children’s Hospital Colorado (Children’s Colorado) has announced a new, care-changing test designed by its physicians to monitor inflammation of the gastrointestinal ...
Liquid biopsy ctDNA reveals targets and flags residual disease in esophageal and gastric cancers, hinting at earlier relapse detection and tailored care.
SAN DIEGO — A real-time, blood-sensing capsule (PillSense) is a safe and effective diagnostic tool for patients with suspected upper gastrointestinal (GI) bleeding that can aid patient triage, reduce ...
Phase II trial of transarterial chemoembolization followed by sintilimab (anti-PD-1), oxaliplatin, and S-1 combined with either trastuzumab (HER-2 positive) or apatinib (HER-2 negative) as first-line ...
An esophagogastroduodenoscopy (EGD) is a procedure that helps diagnose and treat conditions of the upper gastrointestinal (GI) tract. During the EGD procedure, a doctor passes an endoscope, a camera ...
Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
Multigene germline testing has become relatively inexpensive, thereby making universal germline testing for all patients with GI cancer feasible. Such systematic approaches would greatly simplify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results